Skip to main content
European Commission logo
español español
CORDIS - Resultados de investigaciones de la UE
CORDIS
Contenido archivado el 2024-06-16

European human embryonic stem cell registry

Objetivo

Human embryonic stem cell (hESC) research holds promise for the development of therapies for degenerative pathologies, offers a tool for drug discovery and toxicity tests, for studying human development, disease physiology and gene control. hESC lines are currently derived in an increasing number of laboratories in Europe and around the world. A detailed registry of available cell lines will promote the validation and efficient use of these precious cells for research and application.

Comparable information is needed about the origin of the cell lines, the methodology and standards for their derivation and the characteristics to assess their availability for research and future therapies. The growing use of hESC by the scientific community demands a high quality and comprehensive registry. The aim of the proposed European hESC registry is to promote access to all hESC lines derived in Europe and transparency about their characteristics.

Convocatoria de propuestas

FP6-2005-LIFESCIHEALTH-6
Consulte otros proyectos de esta convocatoria

Régimen de financiación

SSA - Specific Support Action

Coordinador

CHARITÉ - UNIVERSITÄTSMEDIZIN BERLIN
Aportación de la UE
Sin datos

Participantes (13)